Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexFemale
Age18+
SponsorTriHealth Inc.

About this trial

The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine from the bladder into a collection bag).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Any surgery involving a non-urogynecologist

Patients already on an alpha blocker

Baseline hypotension

History of syncope

Trial design

Design model

Parallel

Treatments tested in this trial

  • Tamsulosin

    Drug

    This intervention will investigate if tamsulosin will decrease postoperative urinary retention. Subjects will be directed to start taking the medication 5-7 days prior to their procedure; as previous studies have shown, this is when tamsulosin reaches its steady state. Patients will continue to take their assigned pills for 7 days postoperatively.

  • Placebo

    Drug

    This intervention will ensure blinding and an accurate measure of the real effect of tamsulosin.

Treatment groups

166 Participants
are divided into 2 treatment groups
Group A: Study ArmActive comparator 1 intervention
Group B: Control ArmPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Voiding trial on postoperative day 0

Whether or not patients pass or fail their postoperative voiding trial

Time frame
Day of surgery

Secondary outcomes

1

Secondary postoperative urinary retention

Patients who develop urinary retention after discharge

Time frame
2 weeks following surgery
2

Postoperative urinary tract infection

Patients who develop a urinary tract infection after surgery

Time frame
30 days after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.